BRISBANE, Calif., July 20 /PRNewswire-FirstCall/ —
InterMune, Inc. (Nasdaq: ITMN) today announced that it will release second
quarter 2010 financial results on Tuesday,
July 27, 2010 at 4:00 p.m. Eastern
time. A live conference call and webcast will be
hosted by InterMune at 4:30 p.m. Eastern
time that same day.
To access the live teleconference, dial 888-799-0528 (U.S.) or
973-200-3372 (international), conference ID# 85459924. To
access the webcast, please log on to the company’s website at www.intermune.com at least 15
minutes prior to the start of the call to ensure adequate time for
any software downloads that may be required.
A replay of the webcast and teleconference will be available
approximately three hours after the call. The teleconference
replay will be available for 10 business days following the call
and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291
(international), and entering the conference ID# 85459924.
About InterMune
InterMune is a biotechnology company focused on the research,
development and commercialization of innovative therapies in
pulmonology and hepatology. InterMune has an R&D
portfolio addressing idiopathic pulmonary fibrosis (IPF) and
hepatitis C virus (HCV) infections. The pulmonology portfolio
includes pirfenidone, for which InterMune has completed the Phase 3
CAP
‘/>”/>
